Buy These 2 Likely Biotech Takeover Targets

EGRX, BDSI: their cutting-edge drug portfolios and profitable relationships with industry heavyweights make these two rapidly advancing biotech companies prime takeover targets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.